GlobalRPh Renal Dosing Masterv6.6
v6.0 | 2026-09-10

Verified destination.
Not automatic clinical approval.

The original I and F technical backlogs are reconciled. Other URL, retrieval and source-quality gaps remain visible below.

130 / 130Prior I resolver destinations reconciled
88 / 88Prior F candidate destinations reconciled
502D entries checked in v6.0 (of502 listed)
0 / 26Directories with complete clinical review

What these results do and do not establish

All 502 D entries have recorded retrieval outcomes: 430 returned text and 72 failed. There are 433 known exact destination URLs and 69 unresolved destinations. No failure-retry pass is claimed.

All 26 directory attempt logs are now recorded. All 26 still require complete monograph review and independent clinical sign-off. The full deduplicated monograph denominator remains unestablished.

One earlier exact-URL SUPRANE failure recovered through D. Official-label alternatives do not turn failed RX retrievals into successful RX imports.

0 directories still lack complete entry-attempt logs: . All 26 still need full monograph review and independent clinical-review closure.

All 26 letter statusesClinical review points

Cumulative Detailed letter coverage

These totals combine retained prior logs and v6.0 checks. They are directory entries, not unique drugs or complete monographs.

LetterDetailed attempted entriesExact URLs knownURLs still unknownContent returned at least onceNo content recovery
A763763074617
B36136103601
C624 /624 listed (attempt log complete)466158400224
D5024336943072
E40940904072
F3242863827846
I35935903590
L42442044204
M47046644664
N36336303621
O25725252525
P566566054719
R312312030111
S432432041022
T55255205448

Known URLs can still fail to return content. Returned content can still be partial. Earlier detailed letter results were not re-fetched wholesale. Counts preserve earlier observations plus all 502 D outcomes and the SUPRANE exact-URL recovery. C and D attempt logs are complete; full clinical reviews are not. Reader link numbers are scoped to the recorded rendering, not stable product identifiers. Product labels may be derived from observed destination slugs; exact clinical identity requires reading the source body.

Find an entry or unresolved issue

Use drug/source terms only, never patient identifiers. Filters are in the URL. No JavaScript is required; CSV includes every match, not just the visible page.

63 matching entries; page 2 of 2.

Directory P | reader link 111

PEDIAZOLE

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.0. Recorded outcome: partial rendering no import.

https://globalrph.com/rx-list/pediazole-drug/

Source-quality limitation: Rendering ends during the pediatric dosing schedule; no new RX renal summary imported. Prior source limitation retained; a returned page alone does not repair it.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Directory P | reader link 400

POTIGA

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.0. Recorded outcome: partial rendering no import.

https://globalrph.com/rx-list/potiga-drug/

Source-quality limitation: Historical rendering ends during an adverse-event table. Full monograph and current product status not established; no new RX renal summary imported. Prior source limitation retained; a returned page alone does not repair it.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Directory P | reader link 408

GAVRETO

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.0. Recorded outcome: limited sections imported.

https://globalrph.com/rx-list/gavreto-drug/

Source-quality limitation: The RX text supplies a 30-89 supported PK range and prints less than15 for the severe-impairment unknown. The15-29 gap remains unreconciled; no dose or silent correction is inferred.

Actual local content associated with this RX URL

Directory P | reader link 410

MIRAPEX

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.0. Recorded outcome: limited sections imported.

https://globalrph.com/rx-list/mirapex-drug/

Source-quality limitation: The URL is named mirapex, but the retrieved source body identifies MIRAPEX ER. Selected ER instructions are imported only for the ER record. Not a source for immediate-release dosing; the new IR record uses a separate exact DailyMed label.

Actual local content associated with this RX URL

Directory P | reader link 573

MOTEGRITY

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.0. Recorded outcome: partial rendering no import.

https://globalrph.com/rx-list/motegrity-drug/

Source-quality limitation: The RX rendering contains only a short description and lacks its renal prescribing section. No new RX renal summary imported; the official DailyMed supplement is separate. Prior source limitation retained; a returned page alone does not repair it.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Directory R | reader link 145

rezdiffra

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.2. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/rezdiffra-drug/

Source-quality limitation: March 2024 mirror leaves severe impairment unstudied; July 2026 official section includes severe-impairment evidence. Read the newer official card; this is a dated-source difference.

Actual local content associated with this RX URL

Directory R | reader link 223

wayrilz

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.2. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/wayrilz-drug/

Source-quality limitation: Selected RX rendering provides PK but omits the full categorical renal instruction. Official section 8.7 advises avoidance in severe impairment; do not invent a numeric cutoff.

Actual local content associated with this RX URL

Directory S | reader link 103

sephience

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.3. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/sephience-drug/

Source-quality limitation: Selected renal PK information is unknown; incomplete selected sections do not establish a no-adjustment instruction or a human dose cutoff from animal findings.

Actual local content associated with this RX URL

Directory S | reader link 242

sovaldi

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.3. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/sovaldi-drug/

Source-quality limitation: The retrieved SOVALDI label retains a severe-renal/ESRD limitation; regimen-level HCV guidance discusses sofosbuvir-containing regimens. Exact product/regimen adjudication is required; no blended dose supplied.

Actual local content associated with this RX URL

Directory S | reader link 306

carospir

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.3. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/carospir-drug/

Source-quality limitation: The suspension is not therapeutically equivalent to ALDACTONE tablets. The renal starting-amount sentence does not state a separate frequency; a tablet alternate-day schedule is not substituted.

Actual local content associated with this RX URL

Directory S | reader link 385

sulfamylon

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.3. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/sulfamylon-drug/

Source-quality limitation: Historical mirror concerns mafenide 5% topical solution. Current official product-label review remains open; do not apply its findings to cream or infer a numerical renal schedule.

Actual local content associated with this RX URL

Directory S | reader link 421

journavx

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.3. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/journavx-drug/

Source-quality limitation: Official and mirror renal paragraphs use <15 and >15 mL/min, while PK includes >=15. Exact 15 is not assigned by this tool; absolute versus indexed eGFR must be retained.

Actual local content associated with this RX URL

Directory T | reader link 38

tadliq

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/tadliq-drug/

Source-quality limitation: The printed dosage bands omit exact CrCl 30 mL/min. Do not fill the boundary or substitute an ED regimen.

Actual local content associated with this RX URL

Directory T | reader link 39

adcirca

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/adcirca-drug/

Source-quality limitation: The printed PAH dosage bands omit exact CrCl 30 mL/min. No inferred boundary assignment.

Actual local content associated with this RX URL

Directory T | reader link 53

talzenna

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/talzenna-drug/

Source-quality limitation: The RX moderate-renal mCRPC dose differs from the rechecked official section 2.6. Disputed mirror text is retained only to document the difference, not as prescribing permission.

Actual local content associated with this RX URL

Directory T | reader link 81

imdelltra

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: content returned not full review.

https://globalrph.com/rx-list/imdelltra-drug/

Source-quality limitation: The returned page contains a technical-difficulties message rather than a monograph. It counts only as returned page content, not a recovered clinical monograph.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Directory T | reader link 190

terlivaz

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/terlivaz-drug/

Source-quality limitation: Selected RX text lacks the full pictured adjustment pathway; separately retrieved official HTML and its visually inspected figure provide the local pathway. This does not certify complete RX recovery.

Actual local content associated with this RX URL

Directory T | reader link 258

thiola

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/thiola-drug/

Source-quality limitation: Index wording refers to delayed release but this monograph identifies immediate-release 100 mg tablets. Local scope follows the monograph body, not the index label.

Actual local content associated with this RX URL

Directory T | reader link 259

thiola-ec

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/thiola-ec-drug/

Source-quality limitation: Index wording is nonspecific while the monograph identifies THIOLA EC delayed-release tablets. Local scope follows the body and dosage-form section.

Actual local content associated with this RX URL

Directory T | reader link 293

ticlast

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: content returned not full review.

https://globalrph.com/rx-list/ticlast-drug/

Source-quality limitation: The Ticlast page contains a Dymista nasal-spray description and no complete renal monograph. No clinical import is made from this mismatched partial rendering.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Directory T | reader link 295

tigan

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/tigan-drug/

Source-quality limitation: The selected capsule source specifies lengthening the interval, without a fixed reduced interval, and prints indexed CrCl units. Current exact-label/method clarification remains open.

Actual local content associated with this RX URL

Directory T | reader link 403

cyklokapron

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: selected sections imported.

https://globalrph.com/rx-list/cyklokapron-drug/

Source-quality limitation: The printed IV serum-creatinine table repeats 2.83 mg/dL in adjacent bands. Exact boundary requires clarification; not a CrCl table.

Actual local content associated with this RX URL

Directory T | reader link 439

yutrepia

Exact destinationObserved destination; availability separate
Content recoveryReturned at least once
Clinical closureIncomplete

Exact destination observed in returned source.

Last entry check: v5.4. Recorded outcome: content returned not full review.

https://globalrph.com/rx-list/yutrepia-drug/

Source-quality limitation: T-index Yutrepia entry and returned body describe injection/infusion. Exact product-route identity has not been established; no YUTREPIA clinical import is made.

No local summary is linked to this exact RX URL. An official alternative, when available, is a separate source and is not counted here as an RX import.

Preserved history and present limitations

Earlier failures remain in their original release logs. They are not rewritten as if the later success happened earlier. The current reconciliation layer shows subsequent recovery separately. The first-100 external-source inventory and the other letter logs have their own review boundaries.

Release-by-release attempt historyComplete content coverage